Clinic epidemiological evaluation of co morbidities in patients with psoriasis in a tertiary care hospital

• Main Author: SK Jaffer Basha
• Format: Article
• Language: English
• Published: Prathima Institute of Medical Sciences 2020-12-01
• Series: Perspectives In Medical Research
• Subjects: psoriasis; co morbidities; epidemiological study
• Online Access: https://www.pimr.org.in/2020-vol8-issue-3/originalarticle1_v1.pdf

Background: Psoriasis is a common disease presented to the dermatology clinics. There are several reports concerning co morbidities in patients with psoriasis. Some of them include diabetes mellitus, hypertension, dyslipidemia, obesity, IHD, ulcerative colitis. Hence, we in the present study tried to evaluate the existing comorbidities in patients diagnosed with psoriasis in presenting to our hospital. Methods: This study was conducted in the Department of Dermatology, Venereology, and Leprosy, Prathima Institute of Medical Sciences, Karimnagar. This case-control study evaluated the prevalence of diabetes mellitus, hypertension, obesity, dyslipidemia and metabolic syndrome in patients with psoriasis. The existence of hypertension, diabetes mellitus, dyslipidemia, obesity was determined by standard criteria. The data was recorded and analyzed using SPSS version 17 for p values. Results: BSL (Blood Sugar Level) derangement as increased fasting BSL was observed in 23 (23%) cases compared to 8(8%) controls. There was a statistically significant difference between psoriatic cases and controls. The total number of male patients with raised waist circumference was 24 (33.8%) compared to 9(13.2%) controls. There was a statistically significant association of raised waist circumference in psoriasis cases compared to controls, the p-value was <0.004. The existence of metabolic syndrome was 27% in the study group and 8% in the control group the p values were <0.004 and significant. Conclusion: The results of the present shows that there is a significant prevalence of psoriasis in males as compared to females. There is a significant association of metabolic syndrome in patients with psoriasis. Hence all the patients with psoriasis need to be evaluated for metabolic syndrome which may be a risk factor for systemic diseases